MYP_148781
Basic Information
Ipilimumab
Anticancer
Immunology Immune checkpoint modulation Immune checkpoint inhibitor
Immunology Immunomodulation Immunotherapy
Standard
243 amino acids
C1158H1785N309O354S9
Standard
Sequence
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHTCPPCPAPELLGGPSVFL
Physicochemical Analysis
25988.00 Da
8.93
6.04
5.48
0.0249
-0.17
0.47
0.09
51.73
70.53
0.1029
43890.00
44265.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0116692 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Monoclonal antibody
9606
Structure & Mods
linear multidomain protein biologic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Anticancer Immunotherapy Immune checkpoint inhibitor
0.2 μg/mL
EC50
Terminal Elimination Half-life: 14.7 -15.4 d